Literature DB >> 23237510

Cross-reactivity of T cells and its role in the immune system.

Galina Petrova1, Andrea Ferrante, Jack Gorski.   

Abstract

T-cell receptors recognize peptides presented by the major histocompatibility complex (MHC) on the surface of antigen-presenting cells (APC). The ability of the T-cell receptor (TCR) to recognize more than one peptide-MHC structure defines cross-reactivity. Cross-reactivity is a documented phenomenon of the immune system whose importance is still under investigation. There are a number of rational arguments for cross-reactivity. These include the discrepancy between the theoretical high number of pathogen-derived peptides and the lower diversity of the T-cell repertoire, the need for recognition of escape variants, and the intrinsic low affinity of this receptor-ligand pair. However, quantifying the phenomenon has been difficult, and its immunological importance remains unknown. In this review, we examined the cases for and against an important role for cross reactivity. We argue that it may be an essential feature of the immune system from the point of view of biological robustness.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23237510      PMCID: PMC3595599          DOI: 10.1615/critrevimmunol.v32.i4.50

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  161 in total

1.  Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency.

Authors:  B Hemmer; C Pinilla; B Gran; M Vergelli; N Ling; P Conlon; H F McFarland; R Houghten; R Martin
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

2.  A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex.

Authors:  Jean Baptiste Reiser; Claude Grégoire; Claudine Darnault; Thomas Mosser; Annick Guimezanes; Anne Marie Schmitt-Verhulst; Juan Carlos Fontecilla-Camps; Gilbert Mazza; Bernard Malissen; Dominique Housset
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

Review 3.  T cell receptors: affinities, cross-reactivities, and a conformer model.

Authors:  Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2004-02       Impact factor: 4.407

4.  How a single T cell receptor recognizes both self and foreign MHC.

Authors:  Leremy A Colf; Alexander J Bankovich; Nicole A Hanick; Natalie A Bowerman; Lindsay L Jones; David M Kranz; K Christopher Garcia
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

5.  T cell allorecognition via molecular mimicry.

Authors:  Whitney A Macdonald; Zhenjun Chen; Stephanie Gras; Julia K Archbold; Fleur E Tynan; Craig S Clements; Mandvi Bharadwaj; Lars Kjer-Nielsen; Philippa M Saunders; Matthew C J Wilce; Fran Crawford; Brian Stadinsky; David Jackson; Andrew G Brooks; Anthony W Purcell; John W Kappler; Scott R Burrows; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

6.  Modification of the HER2/NEU-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes.

Authors:  Y Tanaka; K D Amos; H G Joo; T J Eberlein; P S Goedegebuure
Journal:  Int J Cancer       Date:  2001-11       Impact factor: 7.396

7.  Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.

Authors:  L B Nicholson; H Waldner; A M Carrizosa; A Sette; M Collins; V K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

8.  A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6.

Authors:  Lazar Vujanovic; Maja Mandic; Walter C Olson; John M Kirkwood; Walter J Storkus
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

9.  Effector T cells have a lower ligand affinity threshold for activation than naive T cells.

Authors:  Kazuhiko Kimachi; Katsuji Sugie; Howard M Grey
Journal:  Int Immunol       Date:  2003-07       Impact factor: 4.823

10.  Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals.

Authors:  Paula M Acierno; Danforth A Newton; Edwin A Brown; Lou Anne Maes; John E Baatz; Sebastiano Gattoni-Celli
Journal:  J Transl Med       Date:  2003-08-14       Impact factor: 5.531

View more
  40 in total

Review 1.  Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.

Authors:  Maran L Sprouse; Nicholas A Bates; Krysta M Felix; Hsin-Jung Joyce Wu
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

2.  A study of CDR3 loop dynamics reveals distinct mechanisms of peptide recognition by T-cell receptors exhibiting different levels of cross-reactivity.

Authors:  Yuko Tsuchiya; Yoshiki Namiuchi; Hiroshi Wako; Hiromichi Tsurui
Journal:  Immunology       Date:  2017-11-08       Impact factor: 7.397

3.  Current challenges for unseen-epitope TCR interaction prediction and a new perspective derived from image classification.

Authors:  Pieter Moris; Joey De Pauw; Anna Postovskaya; Sofie Gielis; Nicolas De Neuter; Wout Bittremieux; Benson Ogunjimi; Kris Laukens; Pieter Meysman
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

4.  Frequency determination of breast tumor-reactive CD4 and CD8 T cells in humans: unveiling the antitumor immune response.

Authors:  Mariana Pereira Pinho; Thiago Andrade Patente; Elizabeth Alexandra Flatow; Federica Sallusto; José Alexandre Marzagão Barbuto
Journal:  Oncoimmunology       Date:  2019-05-15       Impact factor: 8.110

Review 5.  Non-canonical B cell functions in transplantation.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Hum Immunol       Date:  2019-04-10       Impact factor: 2.850

Review 6.  TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity.

Authors:  Jennifer D Stone; Daniel T Harris; David M Kranz
Journal:  Curr Opin Immunol       Date:  2015-01-22       Impact factor: 7.486

7.  Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction.

Authors:  Gabriele G Schiattarella; Pilar Alcaide; Gianluigi Condorelli; Thomas G Gillette; Stephane Heymans; Elizabeth A V Jones; Marinos Kallikourdis; Andrew Lichtman; Federica Marelli-Berg; Sanjiv Shah; Edward B Thorp; Joseph A Hill
Journal:  Nat Cardiovasc Res       Date:  2022-03-14

8.  NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.

Authors:  Lori Blanchfield; Joseph J Sabatino; Laurel Lawrence; Brian D Evavold
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

9.  Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.

Authors:  Arbor G Dykema; Boyang Zhang; Bezawit A Woldemeskel; Caroline C Garliss; Laurene S Cheung; Dilshad Choudhury; Jiajia Zhang; Luis Aparicio; Sadhana Bom; Rufiaat Rashid; Justina X Caushi; Emily Han-Chung Hsiue; Katherine Cascino; Elizabeth A Thompson; Abena K Kwaa; Dipika Singh; Sampriti Thapa; Alvaro A Ordonez; Andrew Pekosz; Franco R D'Alessio; Jonathan D Powell; Srinivasan Yegnasubramanian; Shibin Zhou; Drew M Pardoll; Hongkai Ji; Andrea L Cox; Joel N Blankson; Kellie N Smith
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

10.  SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

Authors:  Annika Nelde; Tatjana Bilich; Jonas S Heitmann; Yacine Maringer; Helmut R Salih; Malte Roerden; Maren Lübke; Jens Bauer; Jonas Rieth; Marcel Wacker; Andreas Peter; Sebastian Hörber; Bjoern Traenkle; Philipp D Kaiser; Ulrich Rothbauer; Matthias Becker; Daniel Junker; Gérard Krause; Monika Strengert; Nicole Schneiderhan-Marra; Markus F Templin; Thomas O Joos; Daniel J Kowalewski; Vlatka Stos-Zweifel; Michael Fehr; Armin Rabsteyn; Valbona Mirakaj; Julia Karbach; Elke Jäger; Michael Graf; Lena-Christin Gruber; David Rachfalski; Beate Preuß; Ilona Hagelstein; Melanie Märklin; Tamam Bakchoul; Cécile Gouttefangeas; Oliver Kohlbacher; Reinhild Klein; Stefan Stevanović; Hans-Georg Rammensee; Juliane S Walz
Journal:  Nat Immunol       Date:  2020-09-30       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.